AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (June 6, 2003). doi:10.1152/ajplung.00377.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/L808    most recent
00377.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vargaftig, B. B.
Right arrow Articles by Singer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vargaftig, B. B.
Right arrow Articles by Singer, M.
Submitted on November 5, 2002
Accepted on May 28, 2003

Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR

Bernardo Boris Vargaftig1 and Monique Singer1*

1 Unite de Pharmacologie Cellulaire, Institut Pasteur-INSERM U485, Paris, France, France, Metropolitan

* To whom correspondence should be addressed. E-mail: msinger{at}pasteur.fr.

Antigen induces murine bronchial hyperreactivity (BHR), inflammation, mucus accumulation and airways remodelling. To investigate whether leukotrienes (LT) mediate the effects of antigen (ovalbumin, Ova), we studied 5-lipoxygenase (5-LO) expression in immunized BP2 mice and prevented LT synthesis with the 5-LO inhibitor zileuton or antagonized their effects with receptor antagonists (Cys-LT-ra: MK-571, LY 171883; LTB4-ra: PH-163). Cys-LT content increased in the bronchoalveolar lavage fluid (BALF) already 15 min. after the intratracheal instillation (i.t.) of Ova. Zileuton inhibited LT release in the BALF, eosinophil recruitment in the lungs, and dose-dependently reduced BHR, mucus accumulation, and remodelling, as did the LT-ra. Thus LT, released just after antigen challenge, might constitute the first step accounting for the effects of Ova. Since mucus accumulation is regulated via EGFR, which is also implicated in the effects of LT, we studied this pathway using AG 1478, an EGFR tyrosine kinase inhibitor given at 0.5, 4 and 20 mg/kg. AG 1478 inhibited BHR, inflammation and lung remodelling induced by Ova, or by molecules themselves generated by Ova, such as LT, IL-13, MCP-1, which promote identical effects, suggesting the involvement of the EGFR pathway in the asthma-like syndrome observed.




This article has been cited by other articles:


Home page
Eur Respir JHome page
M. Tamaoka, M. Hassan, T. McGovern, D. Ramos-Barbon, T. Jo, Y. Yoshizawa, B. Tolloczko, Q. Hamid, and J. G. Martin
The epidermal growth factor receptor mediates allergic airway remodelling in the rat
Eur. Respir. J., November 1, 2008; 32(5): 1213 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. D. Hardie, C. Davidson, M. Ikegami, G. D. Leikauf, T. D. Le Cras, A. Prestridge, J. A. Whitsett, and T. R. Korfhagen
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-{alpha}-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1217 - L1225.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. P. L. de Oliveira, H. V. Domingos, G. Cavriani, A. S. Damazo, A. L. dos Santos Franco, S. M. Oliani, R. M. Oliveira-Filho, B. B. Vargaftig, and W. T. de Lima
Cellular recruitment and cytokine generation in a rat model of allergic lung inflammation are differentially modulated by progesterone and estradiol
Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1120 - C1128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. L. Kramer, G. H. Deutsch, M. A. Sartor, W. D. Hardie, M. Ikegami, T. R. Korfhagen, and T. D. Le Cras
Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L314 - L327.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Boxall, S. T. Holgate, and D. E. Davies
The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma
Eur. Respir. J., January 1, 2006; 27(1): 208 - 229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. D. Nelin, L. G. Chicoine, K. M. Reber, B. K. English, T. L. Young, and Y. Liu
Cytokine-Induced Endothelial Arginase Expression Is Dependent on Epidermal Growth Factor Receptor
Am. J. Respir. Cell Mol. Biol., October 1, 2005; 33(4): 394 - 401.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P-R Burgel and J A Nadel
Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium
Thorax, November 1, 2004; 59(11): 992 - 996.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.